Abu Dhabi’s PureHealth Expands Its Global Reach With Greek And Cypriot Hospital Takeover

by THEFUTURE.TEAM

January 28, 2025

Abu Dhabi’s state-owned PureHealth Holding PJSC is set to acquire a 60% stake in the Greek healthcare giant Hellenic Healthcare Group (HHG) in a deal valued at around $2.3 billion. This move signals a major shift in the private healthcare sector in Greece and Cyprus.

CVC Capital Partners, currently holding a 35% stake in HHG, will retain its share. At the same time, the founder of the Greek healthcare provider will maintain the remaining ownership, according to the agreement’s details.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The deal brings together HHG’s impressive portfolio, which includes some of Greece’s most renowned hospitals—Metropolitan, Hygeia, Metropolitan General, and Mitera—alongside key medical facilities in Cyprus, such as Apollonion Private Hospital, Aretaeio, and American Medical Center.

With this acquisition, PureHealth aims to drive growth by attracting more international patients and expanding its operations within Greece and Cyprus. The company has also indicated its interest in further acquisitions in the future.

PureHealth, with a market capitalization of around $11 billion, operates more than 100 hospitals and 300 clinics worldwide, employing over 56,000 staff. Recently, the company expanded its footprint by acquiring Circle Health Group, the UK’s largest private hospital network.

This acquisition aligns with PureHealth’s long-term strategy to generate half of its revenue from outside the Gulf Cooperation Council (GCC) countries. It also supports Abu Dhabi’s broader goals of diversifying its economy beyond oil and expanding its global healthcare presence.

HHG, established in 2018, currently operates 1,630 hospital beds across its network, serving over 1.3 million patients annually. With a workforce of more than 5,359 employees, the group also works with 6,662 doctors. In addition to its hospitals, HHG owns diagnostic centers such as HealthSpot and Platon Diagnosis, along with offering home healthcare services and medical equipment trading.

CVC first entered the Greek healthcare sector in 2017 by acquiring a majority stake in Metropolitan Hospital and has since expanded its portfolio with acquisitions of Iaso General Clinic and the Hygeia Group.

The Future Forbes Realty Global Properties

OpenAI Releases GDPval Benchmark To Gauge AI Performance Against Human Experts

by THEFUTURE.TEAM

September 26, 2025

New Benchmark Sheds Light on AI’s Capabilities

OpenAI has unveiled GDPval, a new benchmark designed to evaluate its AI models against human professionals across a broad spectrum of industries. This initiative represents a critical step in understanding how far today’s AI is from matching or surpassing the work quality of experts in sectors such as healthcare, finance, manufacturing, and government.

Methodology and Industry Scope

The GDPval benchmark focuses on nine major industries contributing to America’s gross domestic product and tests AI performance in 44 distinct occupations—from software engineering to nursing and journalism. In its initial version, GDPval-v0, industry professionals compared reports generated by AI models with those produced by their human counterparts. For instance, investment bankers were tasked with evaluating competitor landscape analyses for the last-mile delivery industry, ensuring that the assessment reflects real-world complexity.

Comparative Performance: AI Advances and Limitations

Results indicate promising progress; OpenAI’s GPT-5-high, an enhanced iteration of its flagship model, achieved a win rate of 40.6% when compared head-to-head with industry veterans. More notably, Anthropic’s Claude Opus 4.1 reached nearly 49% on similar criteria. However, OpenAI acknowledges that these models are not yet positioned to replace human labor entirely, as the current iteration of GDPval covers a narrow slice of actual job responsibilities.

Expert Insights and Future Directions

In a discussion with TechCrunch, OpenAI’s chief economist, Dr. Aaron Chatterji, noted that the benchmark’s favorable outcomes suggest professionals may soon delegate routine tasks to AI. This, he argued, will free up valuable time for focusing on higher-impact work. Industry observer Tejal Patwardhan also expressed optimism, emphasizing the significant performance leap from GPT-4’s 13.7% score to nearly triple that figure with GPT-5.

Benchmarking And The Road To Comprehensive AI Evaluation

While GDPval represents an early milestone, it aligns with a broader effort among Silicon Valley titans to create robust testing frameworks, such as AIME 2025 and GPQA Diamond, that better quantify AI proficiency for real-world applications. OpenAI plans to expand GDPval to encapsulate more industries and interactive workflows, aiming to bolster its claims about AI’s growing economic value.

As the benchmark evolves, GDPval could play an instrumental role in the ongoing debate around artificial general intelligence, highlighting the potential and limitations of AI models poised to reshape the modern workforce.

Breaking news